LADENBURG THALMANN FINANCIAL SERVICES INC. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 165 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$178,000
+41.3%
36,094
-17.0%
0.00%0.0%
Q3 2019$126,000
-51.2%
43,467
+19.1%
0.00%
-50.0%
Q2 2019$258,000
-59.8%
36,502
-18.6%
0.00%
-60.0%
Q1 2019$641,000
-4.2%
44,830
-0.6%
0.01%
-16.7%
Q4 2018$669,000
+66800.0%
45,110
+180340.0%
0.01%
Q3 2018$1,000250.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders